EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017–2023

Masaki Hatano, Akira Okada, Yuya Kimura, Hisatoshi Ishikura, Takeyuki Tanaka, Taku Saito, Sakae Tanaka, Hideo Yasunaga

Bone · 2026-10 · 211 · 117979

DOI: 10.1016/j.bone.2026.117979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026-10. Verfasst von Masaki Hatano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: h-masaki@g.ecc.u-tokyo.ac.jp. Hauptthemen laut MEDLINE: Osteoporosis, Bone Density Conservation Agents, Secondary Prevention, Osteoporotic Fractures. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Government of Japan Ministry of Health Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisBone Density Conservation AgentsSecondary PreventionOsteoporotic FracturesHumansJapanFemaleMaleAgedMiddle AgedCross-Sectional StudiesHip FracturesSpinal FracturesAged, 80 and over

Stichwörter der Autor:innen

Anti-osteoporosis medicationHealth policyHip fracturesOsteoporosisPharmacoepidemiologySecondary fracture preventionSpinal fractures

Substanzen

Bone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: h-masaki@g.ecc.u-tokyo.ac.jp.
  • Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Orthopedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

Förderung

  • Government of Japan Ministry of Health Labour and Welfare

Zitieren

APA

Hatano, M., Okada, A., Kimura, Y., Ishikura, H., Tanaka, T., Saito, T., Tanaka, S., & Yasunaga, H. (2026). Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017–2023. Bone, 211, 117979. https://doi.org/10.1016/j.bone.2026.117979

Vancouver

Hatano M, Okada A, Kimura Y, Ishikura H, Tanaka T, Saito T, et al. Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017–2023. Bone. 2026;211:117979. doi:10.1016/j.bone.2026.117979

BibTeX
@article{Hatano2026,
  author = {Hatano, Masaki and Okada, Akira and Kimura, Yuya and Ishikura, Hisatoshi and Tanaka, Takeyuki and Saito, Taku and Tanaka, Sakae and Yasunaga, Hideo},
  title = {Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017–2023},
  journal = {Bone},
  year = {2026},
  volume = {211},
  pages = {117979},
  doi = {10.1016/j.bone.2026.117979}
}
Kostenlos starten →